{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-009312","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2023-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.582949+00:00","generated_at":"2026-06-17T15:21:39.724794+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"low","headline":"The Oncology Institute issues FY2022 results and 2023 guidance; specific numbers not available in filing text","bullets":["Slide presentation furnished as Exhibit 99.1 includes financial results for Q4 and FY2022.","Presentation also provides business update and guidance for the year ending December 31, 2023.","Exact revenue, EPS, or other financial figures are not disclosed in the provided filing excerpt."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-009312","json":"https://secwatch.observer/filing/0001628280-23-009312.json","markdown":"https://secwatch.observer/filing/0001628280-23-009312.md","text":"https://secwatch.observer/filing/0001628280-23-009312.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000162828023009312/0001628280-23-009312-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000162828023009312/toi-20230327.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T15:21:39.724794+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}